Cooper Companies (NASDAQ:COO) Director Buys $82,130.00 in Stock

The Cooper Companies, Inc. (NASDAQ:COO) Director Maria Rivas acquired 1,000 shares of the stock in a transaction on Thursday, December 18th. The shares were bought at an average price of $82.13 per share, with a total value of $82,130.00. Following the purchase, the director directly owned 11,141 shares of the company’s stock, valued at $915,010.33. The trade was a 9.86% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Cooper Companies Trading Up 0.4%

NASDAQ COO opened at $82.75 on Monday. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $100.24. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30. The stock’s fifty day moving average price is $74.70 and its 200-day moving average price is $72.06. The stock has a market cap of $16.22 billion, a P/E ratio of 44.02, a P/E/G ratio of 2.36 and a beta of 1.05.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.04. The firm had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.Cooper Companies’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.04 EPS. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies declared that its Board of Directors has initiated a stock repurchase program on Wednesday, September 17th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the medical device company to reacquire up to 15.4% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its stock is undervalued.

Analysts Set New Price Targets

A number of brokerages recently weighed in on COO. Citigroup restated a “neutral” rating and issued a $88.00 price objective (up from $72.00) on shares of Cooper Companies in a report on Monday, December 8th. Robert W. Baird boosted their price target on Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a research note on Friday, December 5th. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a research report on Friday, December 5th. The Goldman Sachs Group reissued a “sell” rating and issued a $71.00 target price (up previously from $64.00) on shares of Cooper Companies in a research report on Monday, December 8th. Finally, Mizuho set a $100.00 target price on shares of Cooper Companies and gave the company an “outperform” rating in a research note on Friday, December 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, Cooper Companies currently has an average rating of “Moderate Buy” and an average price target of $90.15.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Bell Investment Advisors Inc lifted its stake in shares of Cooper Companies by 106.3% in the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after purchasing an additional 219 shares during the period. J.Safra Asset Management Corp grew its position in Cooper Companies by 204.8% during the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock valued at $36,000 after buying an additional 340 shares during the period. CYBER HORNET ETFs LLC purchased a new stake in Cooper Companies during the second quarter valued at approximately $36,000. GKV Capital Management Co. Inc. bought a new position in Cooper Companies in the first quarter worth approximately $40,000. Finally, MUFG Securities EMEA plc purchased a new position in shares of Cooper Companies during the 2nd quarter worth $42,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.